Andreas J Steck Selected Research

Myelin-Associated Glycoprotein

1/2020	Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.
1/2017	Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy.
9/2015	Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
2/2009	Immunoglobulin M deposition in cutaneous nerves of anti-myelin-associated glycoprotein polyneuropathy patients correlates with axonal degeneration.
8/2003	Distal motor latency and residual latency as sensitive markers of anti-MAG polyneuropathy.
5/2003	Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies.
3/2003	Microheterogeneity of anti-myelin-associated glycoprotein antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas J Steck Research Topics

Disease

8	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 04/2016 - 02/2004
7	Polyneuropathies (Polyneuropathy) 05/2014 - 03/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 03/2006
3	Myasthenia Gravis 04/2005 - 03/2003
2	Multiple Sclerosis 04/2016 - 04/2005
2	Stroke (Strokes) 01/2011 - 12/2009
2	Neoplasms (Cancer) 10/2006 - 09/2004
1	Pelizaeus-Merzbacher Disease 09/2015
1	Hereditary Spastic Paraplegia 09/2015
1	Pain (Aches) 06/2011
1	Cerebral Infarction 01/2011
1	Infarction (Infarctions) 01/2011
1	Ischemia 01/2011
1	Ischemic Stroke 01/2011
1	Mannose-Binding Protein Deficiency 01/2011
1	Vasculitis (Vasculitides) 08/2010
1	POEMS Syndrome (Syndrome, POEMS) 06/2009
1	Demyelinating Diseases (Demyelinating Disease) 10/2006
1	Nervous System Diseases (Neurological Disorders) 04/2005
1	Inclusion Body Myositis 04/2005
1	Celiac Disease (Celiac Sprue) 09/2004
1	Encephalitis (Encephalitis, Rasmussen) 09/2004
1	Miller Fisher Syndrome (Fisher Syndrome) 09/2004
1	Guillain-Barre Syndrome 02/2004
1	Paraproteinemias (Monoclonal Gammopathy) 02/2004
1	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2004
1	Hypertension (High Blood Pressure) 03/2003
1	Thymoma (Thymic Carcinoma) 03/2003
1	Inflammation (Inflammations) 01/2003
1	Tic Disorders (Tic Disorder) 05/2002
1	Blepharospasm 05/2002
1	Tics (Tic) 05/2002

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin M (IgM)IBA 01/2020 - 05/2003
7	Myelin-Associated GlycoproteinIBA 01/2020 - 03/2003
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016 - 03/2003
4	AntibodiesIBA 06/2009 - 03/2003
3	AutoantibodiesIBA 01/2020 - 09/2004
2	EpitopesIBA 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 04/2016 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 04/2016 - 06/2009
2	Rituximab (Mabthera)FDA Link 10/2006 - 05/2003
1	CarbohydratesIBA 01/2017
1	env Gene ProductsIBA 04/2016
1	temelimabIBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	Neutralizing AntibodiesIBA 04/2016
1	Coenzyme A (CoA)IBA 06/2011
1	protachykininIBA 06/2011
1	HLA-DQB1 antigen (HLA DQB1)IBA 06/2011
1	NF-kappa B (NF-kB)IBA 06/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 06/2011
1	EnzymesIBA 06/2011
1	A-factor (Streptomyces)IBA 06/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	C-Reactive ProteinIBA 12/2009
1	Glucose (Dextrose)FDA LinkGeneric 12/2009
1	ParaproteinsIBA 06/2009
1	1-nitrosoindole-3-acetonitrileIBA 10/2008
1	Monoclonal AntibodiesIBA 10/2006
1	Myelin P0 Protein (Myelin Protein Zero)IBA 03/2006
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 09/2004
1	Cisplatin (Platino)FDA LinkGeneric 09/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2004
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2004
1	Anti-Idiotypic AntibodiesIBA 08/2003
1	IceIBA 07/2003
1	Pharmaceutical PreparationsIBA 05/2003
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2003
1	ZincIBA 01/2003
1	Matrix Metalloproteinases (MMPs)IBA 01/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2002
1	Botulinum Toxins (Botulinum Toxin)IBA 05/2002

Therapy/Procedure

2	Plasma Exchange 02/2004 - 03/2003
2	Therapeutics 05/2003 - 03/2003
1	Conservative Treatment 01/2011
1	Aftercare (After-Treatment) 02/2004
1	Thymectomy 03/2003
1	Immunotherapy 03/2003
1	Injections 05/2002